ClinicalTrialsFinder

Abemaciclib Clinical Trials

2 recruiting

Showing 1–2 of 2 trials

Recruiting
Phase 3

Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)

Breast CancerAbemaciclibLocoregional Recurrence+1 more
Japanese Foundation for Cancer Research290 enrolled1 locationNCT07190443
Recruiting

Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)

Breast NeoplasmsBrest CancerAbemaciclib+2 more
University Hospital, Brest30 enrolled1 locationNCT06621459